A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical ...

A novel prediction model estimated 2-year PFS for adults with early-stage classic Hodgkin lymphoma based on four “readily ...

A 27-year-old woman who was diagnosed with stage 2 Hodgkin lymphoma has shared the symptoms she overlooked, and the ones that caused her to reach out to a doctor. advertisement.

A prognostication tool for early classic Hodgkin's lymphoma outperformed a widely used risk-classification system for predicting 2-year progression-free survival. The model uses four variables ...

Antibody and small-molecule treatment either as single agents or in combination with conventional chemotherapy might improve the prognosis of multiple relapsed Hodgkin's lymphoma patients. Figure 2.

Regarding overall survival (OS) at a follow-up of 2.1 years, the OS was 99% in the Opdivo group versus 98% in the Adcetris group, researchers reported. “In addition to ... “Nivolumab+AVD in ...

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma. New England Journal of Medicine , 2024; 391 (15): 1379 DOI: 10.1056/NEJMoa2405888 Cite This Page : ...